Download Kuby Immunology 6/e - Dr. Jennifer Capers

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Chapter 19
Cancer and the Immune System
Dr. Capers
Cancer
Altered self cells
 Unregulated mitosis

○ Produces tumor (neoplasm)
 Benign – does not invade healthy tissue
 Malignant – grows and becomes invasive
- Exhibit metastasis

Malignant cancers are classified according
to embryonic origin of tissue
○ Carcinomas
 Endodermal or ectodermal
 Skin or epithelial lining of internal organs and glands
 Colon, breast, prostate, lung
○ Leukemias and lymphomas
 Tumors of hematopoietic cells of bone marrow
 Leukemias proliferate as single cells
 Lymphomas grow as tumor masses
○ Sarcomas
 Mesodermal connective tissue
 Bone, fat, cartilage

Malignant transformation
 Ability for cell to form cancer
○ Decreased requirements for growth factors
○ No longer anchorage dependent
 What can cause this?
○ Various chemical agents
○ Radiation
○ viruses
Genes that code for
proteins involved in
cell proliferation are
called
proto-oncogenes;
mutations in these
genes can lead to
increased
proliferation

Chromosomal translocations
 Can lead to movement of proto-
oncogenes
 This can lead to increased
transcription and translation of
the protein
Induction of cancer is a multi-step
process
 Multiple and subsequent mutations

Tumors of Immune System

Leukemias or Lymphomas
 Lymphomas
○ Solid tumors in lymphoid tissue
○ Include Hodgkin’s and non-Hodgkin’s lymphomas
 Leukemias
○ Proliferate as single cells
○ Lymphoid or myeloid lineage
○ Acute – appear and progress rapidly, tend to rise
in immature cells
○ Chronic – less aggressive and slow, tend to rise in
mature cells, tend to be in adults
Tumor Antigens

Tumor-specific transplantation antigens
(TSTAs)
○ Unique to tumor cells
○ May arise due to mutation
○ Are presented on Class I MHC

Tumor-associated transplantation antigens
(TATAs)
○ Proteins expressed on normal cells
 Inappropriate expression of embryonic gene
 Overexpression of normal protein

Some antigens are tumor specific

Oncofetal antigens
 Found on normal fetal cells
 Only meant to be expressed during embryological
development
 Suppressed after development of fetus is completed
 If expressed later in adult, could induce
immune response
 Immune system may see these as nonself
 Can lead to cancer
 ~90% of colorectal cancer have CEA
(carcinoembryonic antigen)
Tumor Invasion of Immune System

Anti-tumor antibodies
○ Might actually block sites for CTL to bind

Tumor cells might express less Class I
MHC
○ This prevents CTL-mediated death

Tumor cells may provide poor
costimulatory signals
Cancer Immunotherapy
Manipulation of costimulatory signals
 Enhancement of antigen-presenting cells
 Cytokine therapy

○ Interferons
○ Tumor necrosis factors

Monoclonal Abs may be used for some
tumors
○ Immunotoxins may be linked to kill specific tumor
cell, still being researched
 Radioactive isotope, drugs